Ghada Saad

Ghada Saad

Auto-generated profile, based on publicly available information

Ghada Saad

Faculty of Medicine of Sousse, University of Sousse, Sousse 4002, Tunisia

Research Focus & Metrics

Academic Career Length

12Years (2015-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
14 February 2024 in Advances in Respiratory Medicine
Verified
Journal Article
Open access
PDF file
Ach TaiebAch Taieb
Ach Taieb
NSNassim Ben hadj slama
Nassim Ben hadj slama
GAGorchane Asma
Gorchane Asma
JMJabeur Methnani
Jabeur Methnani
SGSaad Ghada
Saad Ghada
BABen Abdelkrim Asma
Ben Abdelkrim Asma
Long COVID-19, also known as post-acute sequelae of SARS-CoV-2 infection, is a condition where individuals who have recovered from the acute phase of COVID-19 continue to experience a range of symptoms for weeks or even months afterward. While it was initially thought to primarily affect the respiratory system, it has become clear that Long COVID-19 can involve various organs and systems, including the endocrine system, which includes the pituitary gland. In the context of Long COVID-19, there is a growing understanding of the potential implications for the pituitary gland. The virus can directly affect the pituitary gland, leading to abnormalities in hormone production and regulation. This can result in symptoms such as fatigue, changes in appetite, and mood disturbances. Long COVID-19, the persistent and often debilitating condition following acute COVID-19 infection, may be explained by deficiencies in ACTH and Growth hormone production from the pituitary gland. Corticotropin insufficiency can result in the dysregulation of the body’s stress response and can lead to prolonged feelings of stress, fatigue, and mood disturbances in Long COVID-19 patients. Simultaneously, somatotropin insufficiency can affect growth, muscle function, and energy metabolism, potentially causing symptoms such as muscle weakness, exercise intolerance, and changes in body composition. Recently, some authors have suggested the involvement of the pituitary gland in Post COVID-19 Syndrome. The exact mechanisms of viral action on infected cells remain under discussion, but inflammatory and autoimmune mechanisms are primarily implicated. The aim of our study will be to review the main pituitary complications following COVID-19 infection. Moreover, we will explain the possible involvement of the pituitary gland in the persistence of Post COVID-19 Syndrome.

1 December 2015 in Annales d'Endocrinologie
Verified
Journal Article
Closed access
NBNouha Bouali
Nouha Bouali
DHDorra H'mida
Dorra H'mida
SMSoumaya Mougou
Soumaya Mougou
JBJérôme Bouligand
Jérôme Bouligand
BLBesma Lakhal
Besma Lakhal
ASAli Saad
Ali Saad

17 September 2022 in Medical Hypotheses
Verified
Journal Article
Closed access
Ach TaiebAch Taieb
Ach Taieb
BABen Abdelkrim Asma
Ben Abdelkrim Asma
SGSaad Ghada
Saad Ghada
HYHasni Yosra
Hasni Yosra
KMKacem Maha
Kacem Maha
AKAch Koussay
Ach Koussay

1 January 2021 in Pan African Medical Journal
Verified
Journal Article
Open access
GSGhada Saad
Ghada Saad
AAAsma Ben Abdelkrim
Asma Ben Abdelkrim
YAYosra Hasni El Abed
Yosra Hasni El Abed
STSoumaya Tahri
Soumaya Tahri
AGAsma Gorchene
Asma Gorchene
KAKoussay Ach
Koussay Ach
Coronavirus disease 2019 (COVID-19) was first reported in December 2019. The disease is caused by severe acute respiratory syndrome virus corona virus 2 (SARS-CoV-2). Mild respiratory symptoms are the most common manifestations of SARS-CoV-2, but new signs are constantly being discovered as it spreads. Disorders of sodium balance are increasingly described in patients with SARS-CoV-2. We report, here, the cases of two patients presented with COVID-19 and in whom we discovered sodium disorders. The first patient is a 74-year-old man who presented with fatal hypernatremia. The second patient is a 66-years-old man presented with COVID-19 and euvolemic hyponatremia attributed to syndrome of inappropriate anti-diuretic hormone secretion (SIADH). This hyponatremia persisted long after the respiratory signs disappeared. Sodium balance disorders are increasingly described in the literature; special attention should be paid to the electrolyte status of COVID-19 patients. Pathophysiological mechanisms associating SARS-CoV-2 with these disorders are being studied.

15 September 2025 in Diagnostics
Verified
Journal Article
Open access
PDF file
Ach TaiebAch Taieb
Ach Taieb
IBInes Bouzaouache
Ines Bouzaouache
AGAyoub Gasmi
Ayoub Gasmi
AGAicha Ghachem
Aicha Ghachem
IHImen Halloul
Imen Halloul
HMHouda Mhabrech
Houda Mhabrech
Background/Objectives: Non-functional pituitary macroadenomas (NFPMA) are uncommon pituitary lesions that do not cause hormonal hypersecretion and are most often discovered at the macroadenoma stage. Consequently, they are more challenging to diagnose, often mimicking other non-secreting sellar masses, among which hypophysitis should be carefully considered. This study aimed to differentiate between non-functioning pituitary macroadenomas (NFPMA) and hypophysitis, two distinct sellar pathologies with overlapping MRI features, by developing a diagnostic score based on clinical, biological, and radiological criteria. Methods: We conducted a prospective study, including 56 patients with NFPMA and 16 patients with hypophysitis primarily of the lymphocytic subtype. A total of 31 clinical, biological, and radiological variables were analyzed using univariate and multivariate statistical methods to identify significant predictors and to establish a diagnostic score. Results: Nine significant criteria were identified: female sex, headaches, visual disturbances, corticotropic insufficiency, pituitary volume ≤ 7 cm3, loss of the posterior pituitary bright spot, cavernous sinus invasion, optic pathway compression, and pituitary stalk thickening. The established score demonstrated significant performance in predicting the diagnosis of hypophysitis (p < 0.001; Area Under the Curve = 0.967; 95% CI = 0.926–1). The sensitivity and specificity of this score were 93.8% and 87.5%, respectively, using a threshold ≥0.5. The median score was −2 (interquartile range = [−3.5; 0.5]), with extremes ranging from −6.5 to 9. Among these, pituitary stalk thickening emerged as a key diagnostic indicator. Conclusions: This simple and effective multi-parametric score enables rapid and accurate differentiation of hypophysitis from NFPMA, helping to avoid unnecessary surgical interventions and to improve the management of pituitary insufficiencies and may be especially valuable in settings when biopsy is unavailable or risky.

30 September 2020 in Annales d'Endocrinologie
Verified
Journal Article
Closed access
RAR. Ajili
R. Ajili
GSG. Saad
G. Saad
AGA. Gorchène
A. Gorchène
AAA. Ben Abdelkarim
A. Ben Abdelkarim
YHY. Hasni
Y. Hasni
KAK. Ach
K. Ach